IE 11 is not supported. For an optimal experience visit our site on another browser.
UP NEXT
Formula One world champion Red Bull to race down D.C.'s Pennsylvania Ave 04:34
China's middle-class sees decrease in confidence as economy faces slowdown 03:54
New protests at Columbia University after arrest of more than 100 01:38
Jurors and alternates seated in Trump trial as man sets himself on fire outside courthouse 02:53
Iran's foreign minister responds after Israel attacks on Iran 03:23
FAA announces new rest rules for air traffic controllers 01:41
25 years later, a survivor reflects on Columbine school shooting 02:21
Unlikely alliance clears way for House vote on Israel and Ukraine aid 01:25
Iranian FM downplays drones used in Israel strikes as ‘toys that our children play with’ 00:34
Iran’s foreign minister downplays drones used in Israel strikes as ‘toys that our children play with’ 00:36
Meet the Press NOW — April 19 52:54
GOP Rep. Lawler: Democrats must oppose Johnson’s ouster to show they’re ‘serious’ about democracy 08:48
Third GOP lawmaker joins effort to oust Johnson as foreign aid bill clears procedural hurdle 04:27
'We want to celebrate life': A Columbine survivor looks back on years of healing 05:46
Apparent conspiracy theorist sets himself on fire outside of Trump trial 02:01
Special report: Man sets himself on fire outside court as a jury is seated in Trump hush money trial 13:28
Jury seated in Trump hush money trial 06:35
Gazan civilians bombed while sheltering in U.N. school 02:45
Man sets himself on fire outside Trump trial, witness says 02:45
New series ‘The Tattooist of Auschwitz’ tells the story of Holocaust survivors finding love 05:22
Experimental drug saves babies, but FDA hurdle remains 09:15 Dr. Mark Puder of Boston Children’s Hospital developed a treatment with a drug made with fish oil called Omegaven that he’s been using to help reverse fatal liver disease in infants. Despite the drug’s effectiveness, it has yet to be approved by the Food and Drug Administration. Puder says that the FDA has told him they want the usual rigorous controlled study where half the patients get the experimental drug and the other half does not. Puder refuses to do the randomized drug trial because it would mean that some infants may die. Dr. Nancy Snyderman reports. June 8, 2013
Read More UP NEXT
Formula One world champion Red Bull to race down D.C.'s Pennsylvania Ave 04:34
China's middle-class sees decrease in confidence as economy faces slowdown 03:54
New protests at Columbia University after arrest of more than 100 01:38
Jurors and alternates seated in Trump trial as man sets himself on fire outside courthouse 02:53
Iran's foreign minister responds after Israel attacks on Iran 03:23
FAA announces new rest rules for air traffic controllers 01:41 
